TC
MYOK

TFS Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

TFS Capital’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-35,615
Closed -$467K – 482
2017
Q2 		$467K Sell
35,615
-35,444
-50% -$467K 0.18% 180
2017
Q1 		$934K Buy
+71,059
New +$910K 0.3% 108

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TFS Capital's MYOK Position: Q3 2017 in Review

TFS Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2017, closing a stake of 35,615 shares — an estimated $467K sold.

TFS Capital first reported a position in MYOK in Q1 2017 and held it in 2 quarters. The position peaked at $934K in Q1 2017. 115 funds tracked by Wall St. Rank hold MYOK as of Q3 2017.

  • TFS Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 35,615 MyoKardia, Inc. Common Stock shares in Q3 2017, an estimated $467K.
  • TFS Capital first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • TFS Capital's MyoKardia, Inc. Common Stock position peaked at $934K in Q1 2017.
  • 115 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.